Literature DB >> 8392334

A mnemonical or negative-co-operativity model for the activation of adenylate cyclase by a common G-protein-coupled calcitonin-gene-related neuropeptide (CGRP)/amylin receptor.

M Bushfield1, A Savage, N J Morris, M D Houslay.   

Abstract

Both amylin and calcitonin-gene-related neuropeptide (CGRP) activated adenylate cyclase activity in hepatocyte membranes around 5-fold in a dose-dependent fashion, with EC50 values of 120 +/- 14 and 0.3 +/- 0.14 nM respectively. Whereas amylin exhibited normal activation kinetics (Hill coefficient, h approximately 1), CGRP showed kinetics indicative of either multiple sites/receptor species having different affinities for this ligand or a single receptor species exhibiting apparent negative co-operativity (h approximately 0.21). The CGRP antagonist CGRP-(8-37)-peptide inhibited adenylate cyclase stimulated by EC50 concentrations of either amylin or CGRP. Inhibition by CGRP-(8-37) was selective in that markedly lower concentrations were required to block the action of amylin (IC50 = 3 +/- 1 nM) compared with that of CGRP itself (IC50 = 120 +/- 11 nM). Dose-effect data for inhibition of CGRP action by CGRP-(8-37) showed normal saturation kinetics (h approximately 1), whereas CGRP-(8-37) inhibited amylin-stimulated adenylate cyclase activity in a fashion which was indicative of either multiple sites or apparent negative co-operativity (h approximately 0.24). Observed changes in the kinetics of inhibition by CGRP-(8-37) of CGRP, but not amylin-stimulated adenylate cyclase, at concentrations of agonists below their EC50 values militated against a model of two distinct populations of non-interacting receptors each able to bind both amylin and CGRP. A kinetic model is proposed whereby a single receptor, capable of being activated by both CGRP and amylin, obeys either a mnemonical kinetic mechanism or one of negative co-operativity with respect to CGRP but not to amylin. The relative merits of these two models are discussed together with a proposal suggesting that the activation of adenylate cyclase by various G-protein-linked receptors may be described by a mnemonical model mechanism.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8392334      PMCID: PMC1134344          DOI: 10.1042/bj2930229

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  47 in total

1.  Multiple affinity forms of the calcitonin gene-related peptide receptor in rat cerebellum.

Authors:  T K Chatterjee; R A Fisher
Journal:  Mol Pharmacol       Date:  1991-06       Impact factor: 4.436

2.  Cross-reactivity of amylin with calcitonin-gene-related peptide binding sites in rat liver and skeletal muscle membranes.

Authors:  A Chantry; B Leighton; A J Day
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

3.  Amylin increases cyclic AMP formation in L6 myocytes through calcitonin gene-related peptide receptors.

Authors:  G C Zhu; D T Dudley; A R Saltiel
Journal:  Biochem Biophys Res Commun       Date:  1991-06-14       Impact factor: 3.575

Review 4.  Receptor-effector coupling by G proteins.

Authors:  L Birnbaumer; J Abramowitz; A M Brown
Journal:  Biochim Biophys Acta       Date:  1990-05-07

5.  Metabolic effects of hyperglycemia and hyperinsulinemia on fate of intracellular glucose in NIDDM.

Authors:  R R Henry; B Gumbiner; T Flynn; A W Thorburn
Journal:  Diabetes       Date:  1990-02       Impact factor: 9.461

6.  Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide.

Authors:  J M Molina; G J Cooper; B Leighton; J M Olefsky
Journal:  Diabetes       Date:  1990-02       Impact factor: 9.461

Review 7.  The role of amylin in the insulin resistance of non-insulin-dependent diabetes mellitus.

Authors:  B Leighton; G J Cooper
Journal:  Trends Biochem Sci       Date:  1990-08       Impact factor: 13.807

8.  Presence of liver CGRP/amylin receptors in only nonparenchymal cells and absence of direct regulation of rat liver glucose metabolism by CGRP/amylin.

Authors:  T W Stephens; W F Heath; R N Hermeling
Journal:  Diabetes       Date:  1991-03       Impact factor: 9.461

9.  Amylin activates glycogen phosphorylase and inactivates glycogen synthase via a cAMP-independent mechanism.

Authors:  R O Deems; R W Deacon; D A Young
Journal:  Biochem Biophys Res Commun       Date:  1991-01-31       Impact factor: 3.575

10.  Forskolin and ethanol both perturb the structure of liver plasma membranes and activate adenylate cyclase activity.

Authors:  A D Whetton; L Needham; N J Dodd; C M Heyworth; M D Houslay
Journal:  Biochem Pharmacol       Date:  1983-05-15       Impact factor: 5.858

View more
  2 in total

Review 1.  Islet amyloid: a complication of islet dysfunction or an aetiological factor in Type 2 diabetes?

Authors:  A Clark; M R Nilsson
Journal:  Diabetologia       Date:  2004-01-13       Impact factor: 10.122

2.  Analysis of the adenylate cyclase signalling system, and alterations induced by culture with insulin, in a novel SV40-DNA-immortalized hepatocyte cell line (P9 cells).

Authors:  C Livingstone; C MacDonald; B Willett; M D Houslay
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.